AstraZeneca (AZN)

Advertisement

Just one of over 6000 shares you can deal on with IG. Find out more by getting your free guide to spread betting on shares. Losses can exceed your initial deposit

3,383.00p
   
  • Change Today:
    -6.50p
  • 52 Week High: 3,396.00
  • 52 Week Low: 2,591.00
  • Currency: UK Pounds
  • Shares Issued: 1,251.39m
  • Volume: 2,121,350
  • Market Cap: £42,334m
  • RiskGrade: 66
  • Beta: 0.65

Latest ShareCast News

Monday broker round-up UPDATE

Date: Monday 29 Apr 2013

Afren: Liberum Capital shifts target price from 130p to 136p and maintains a hold recommendation.

AstraZeneca ShareCast News

Monday newspaper round-up: BP, AstraZeneca, Sain... 29-Apr-2013 ShareCast
Friday tips round-up: Admiral, AstraZeneca 26-Apr-2013 ShareCast
Friday broker round-up UPDATE 26-Apr-2013 ShareCast
London close: Markets underwhelmed by strong gro... 25-Apr-2013 ShareCast
FTSE 100 movers: Miners lead the risers 25-Apr-2013 ShareCast

AstraZeneca Regulatory News

Director/PDMR Shareholding 14-May-2013 14:00 RNS
Director/PDMR Shareholding 08-May-2013 14:00 RNS
Director/PDMR Shareholding 08-May-2013 14:00 RNS
Director/PDMR Shareholding 02-May-2013 13:00 RNS
Director/PDMR Shareholding 01-May-2013 15:00 RNS

AstraZeneca Newspaper Links

AstraZeneca staff find new jobs ahead of plant c... 30-Dec-2011 Telegraph
AstraZeneca back on top with new drug deals 22-Dec-2011 Daily Mail
ASTRAZENECA TURNS TO ASIA 22-Dec-2011 Express & Star
Chi-Med in £89m deal with Astra 22-Dec-2011 The Scotsman
Astra snaps up generic drug firm in China 09-Dec-2011 The Independent

AstraZeneca Tips & Analysis

Questor:AstraZeneca 22-Dec-2011 Telegraph
Investment Column:AstraZeneca 28-Oct-2011 The Independent
Investment Column: AstraZeneca 23-Jun-2011 The Independent
FTSE live: Banks lead gains, AZ relief 28-Mar-2011 Daily Mail
Patent Woes Threaten Drug Firms 07-Mar-2011 New York Times

AstraZeneca News Wires

MedImmune Announces Zook as President 13-Nov-2008 PR Newswire
Survey Shows Lung Cancer Patients Blamed for The... 12-Nov-2008 PR Newswire
CRESTOR Demonstrates Dramatic CV Risk Reduction ... 09-Nov-2008 PR Newswire

Other AstraZeneca News

FTSE close: Next up; Barclays & UU down 22-Jun-2011 This Is Money
Midas: At last, Dogs are setting the pace 14-May-2011 This Is Money
How to enjoy the dividend revival 14-May-2011 This Is Money
FTSE in-depth: Greene King the toast of analysts 13-May-2011 This Is Money
FTSE preview: Rebound led by defensive stocks 13-May-2011 This Is Money

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 3,383.00p
Change Today -6.50p
% Change -0.19 %
52 Week High 3,396.00
52 Week Low 2,591.00
Volume 2,121,350
Shares Issued 1,251.39m
Market Cap £42,334m
Beta 0.65
RiskGrade 66

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
72.57% above the market average72.57% above the market average72.57% above the market average72.57% above the market average72.57% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
40.42% above the market average40.42% above the market average40.42% above the market average40.42% above the market average40.42% above the market average
44.00% above the sector average44.00% above the sector average44.00% above the sector average44.00% above the sector average44.00% above the sector average
Income
93.19% above the market average93.19% above the market average93.19% above the market average93.19% above the market average93.19% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
94.12% below the market average94.12% below the market average94.12% below the market average94.12% below the market average94.12% below the market average
94.87% below the sector average94.87% below the sector average94.87% below the sector average94.87% below the sector average94.87% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 22
Sell 4
Strong Sell 6
Total 38
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 13-Feb-13 08-Aug-12
Paid 18-Mar-13 10-Sep-12
Amount 190.00¢ 90.00¢

Trades for 17-May-2013

Time Volume / Share Price
16:53 375,000 @ 3,374.17p
16:44 4 @ 3,383.00p
16:41 5,307 @ 3,381.93p
16:41 200 @ 3,384.50p
16:39 6,723 @ 3,383.00p

AstraZeneca Key Personnel

CEO Pascal Soriot

Top of Page